TYNE VALE PHARM LTD - Filleted accounts

Registered number

16366576

TYNE VALE PHARM LTD

Filleted Accounts

30 April 2026

TYNE VALE PHARM LTD
Registered number:		16366576
Balance Sheet
as at 30 April 2026

Notes			2026
£
Current assets
Debtors	3	1,115
Cash at bank and in hand		7,375
		8,490

Creditors: amounts falling due within one year	4	(8,224)

Net current assets			266

Net assets			266

Capital and reserves
Called up share capital			2
Profit and loss account			264

Shareholders' funds			266

The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.




A Evans
Director
Approved by the board on 2 September 2026

TYNE VALE PHARM LTD
Notes to the Accounts
for the period from 6 April 2025 to 30 April 2026


1	Accounting policies

	Basis of preparation
	The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

	Turnover
	Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

	Debtors
	Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts.

	Creditors
	Short term creditors are measured at transaction price (which is usually the invoice price).

	Taxation
	A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

	Provisions
	Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.


2	Employees					2026
Number

	Average number of persons employed by the company					2


3	Debtors					2026
£

	Trade debtors					630
	Other debtors					485
						1,115


4	Creditors: amounts falling due within one year					2026
£

	Trade creditors					1,490
	Taxation and social security costs					6,513
	Other creditors					221
						8,224


5	Loans to directors
	Description and conditions	B/fwd	Paid		Repaid		C/fwd
£			£		£		£
	A Evans
	Directors Loan	-		(20,237)		20,347		110

	C Evans
	Directors Loan	-		(20,236)		20,347		111

		-		(40,473)		40,694		221


6	Controlling party

	The company was controlled by its Directors.


7	Other information

	TYNE VALE PHARM LTD is a private company limited by shares and incorporated in England. Its registered office is:
	44 Tyne Vale
	Stanley
	DH9 6PD